Initiation of antihypertensive drugs to patients with confirmed COVID-19-A population-based cohort study in Sweden.

ABSTRACT:

Purpose

Hypertension is an important risk factor for severe outcomes in patients with COVID-19, and antihypertensive drugs may have a protective effect. However, the pandemic may have negatively impacted health care services for chronic diseases. The aim of this study was to assess initiations of antihypertensive medicines in patients infected by COVID-19.

Methods

A cohort study including all Swedish residents 20-80 years old with a COVID-19 positive test compared with an unexposed group without COVID-19 matched for age, sex, and index date (date of confirmed COVID-19). Data were collected within SCIFI-PEARL, a study including linked data on COVID tests, hospital diagnoses, dispensed prescriptions, and socioeconomic data from Swedish national registers. Initiations of differ

SUBMITTER: Mousa SI 

PROVIDER: S-EPMC9349802 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature